baber/WOPTO huggingface dataset:
Patent JP-H11504229-A (JP)
IPC: A61K9/08
Filed: 1996-04-12
Abstract: A composition suitable for transdermal electrotransport delivery of an agent through a body surface comprises a free acid/base form of an agent to be delivered by transdermal electrotransport, and a salt form of the agent, and optionally a permeation enhancer. Methods of enhancing transdermal electrotransport delivery and of forming a composition for the enhancement of transdermal electrotransport drug delivery, and a transdermal electrotransport delivery device (10) utilizing the compositions of the invention are disclosed.
Patent JP-H10507577-A (JP)
Title: 差込み式整流子とその製造方法
IPC: H01R43/06
Filed: 1996-08-08
Abstract: (57)【要約】
電気絶縁材料からなりその周面にわたって均一に分配され配置された同一構造の溝を有するハブ本体（１）を有している差込み式整流子の場合に、整流子の経路を形成する同一構造のセグメント（５）の各々が半径方向の整列嵌合の連結を形成することにより挿入され、セグメント（５）が、セグメント（５）とセグメントの位置決めを容易にするハブ本体（１）の材料部分の少なくとも一方の過剰寸法に基づく締めつけ力により、ハブ本体（１）に対して移動しないよう保護される。セグメント（５）と溝の少なくとも一方の２つの端部部分（18，21）の領域にのみ、セグメント（５）に加えられる締めつけ力を決定する過剰寸法（Ｘ，Ｚ）が設けられている。
Patent JP-2000506866-A (JP)
Title: アンギオテンシノゲンｍＲＮＡに標的化されたオリゴヌクレオチド
IPC: A61K31/70
Filed: 1997-03-14
Abstract: (57)【要約】
ヒト被験体に投与されて、アンギオテンシノゲンの発現を阻害し、それによってアンギオテンシノゲン誘導性高血圧症を調節し得る、オリゴヌクレオチド、およびその組成物が開示される。
Patent JP-2001512965-A (JP)
IPC: C12N11/08
Filed: 1998-01-27
Abstract: A purified arginine deiminase (ADI) obtained from Mycoplasma arthritidis having the amino acid sequence of SEQ ID NO:2 as well as an isolated nucleic acid molecule containing a nucleotide sequence encoding the amino acid sequence set forth in SEQ ID NO:1 are disclosed. Other aspects of the invention include an expression vector, a cloned gene for expressing the Mycoplasma arthritidis derived ADI, (recombinant) host cells useful in expressing the ADI of the present invention and substantially non-antigenic polymer conjugates containing the ADI of the present invention as well as methods of treating arginine deiminase susceptible conditions in mammals. The arginine deiminase-polymer conjugates have high levels of retained enzyme activity and relatively long circulating lives.
Patent JP-H11507960-A (JP)
Title: 二環式芳香族化合物、これらを含有する組成物及びその使用
IPC: A61K8/49
Filed: 1998-02-09
Abstract: (57)【要約】
本発明は式（I）の新規な二環式化合物及び、ヒトまたは動物の医薬用途（特に、皮膚科、リュウマチ性、呼吸器系、心血管系及び眼科の疾患）のための製薬組成物または、化粧品組成物におけるその使用に関する。
Patent JP-2000507947-A (JP)
Title: 無細胞性赤血球代用物を製造する方法及び装置
IPC: A61K38/42
Filed: 1997-03-27
Abstract: (57)【要約】
実質的にテトラー不含の、実質的にストローマ不含の、重合した、ピリドキシル化されたヘモグロビンの製造方法を開示する。また、ヒトの患者に約５リットル以下の量で注入することができる実質的にテトラマー不含の、実質的にストローマ不含の、重合した、ピリドキシル化されたヘモグロビン生成物を開示する。
Patent JP-2001513948-A (JP)
Title: シリコンオンインシュレータ（ｓｏｉ）集積回路を製造する際にゲッタリングの手段を提供する方法
IPC: H01L21/322
Filed: 1998-10-05
Abstract: (57)【要約】
多数の個別シリコンオンインシュレータ（ＳＯＩ）集積回路を含むＳＯＩウェハから個別ＳＯＩ集積回路を製造する際にゲッタリングの手段を提供する方法であって、個別ＳＯＩ集積回路を得るためにＳＯＩウェハをダイスするためのスクライブレーンの中にゲッタリング材料を位置させるステップを含む。次に、スクライブレーンに沿ってＳＯＩウェハをダイスし、個別ＳＯＩ集積回路のダイスされた端部にゲッタリング材料の一部を残す。この方法は、ＳＯＩ技術において、拡散する不純物を集積回路の活性領域に拡散する前にトラップする、簡単且つ効果的なゲッタリングのための方法を提供する。
Patent JP-H11507199-A (JP)
Title: 遠隔通信システム及びコードレスアクセスサブシステム
IPC: H04M1/72505
Filed: 1997-03-13
Abstract: (57)【要約】
コードレスアクセスサブシステムを自動交換機に結合した遠隔通信システムが既知である。既知のシステムにおいて、コードレスアクセスサブシステムは、マイクロセルラシステムを形成し、コードレスアクセスサブシステムに同期したコードレス端末は、ローカルローミング機能を有する。さらに、呼出制御が予め決定される。遠隔通信システムのコードレス端末がその加入者に応じたアクセス機能を有するようにするために、遠隔通信システムは、加入者に応じた種々のシナリオに依存して呼出をセットアップすることができる呼出制御プロトコルを有する。コードレス端末に同期がとられた自動交換機を介在ネットワークを介して他の自動交換機に結合するとともにコードレス端末のホームプロフィールが他の自動交換機にある場合、コードレス端末がそのホームプロフィールの全ての形態を有することができるリモートシナリオを実行することができる。その結果、種々の加入者を有する端末を、相違する方法で取り扱うことができる。コードレスアクセスサブシステムが、呼出制御サブステップメッセージを、端末識別情報及び情報を設けたユーザを含む単一メッセージの形態でネットワークの残りに送信するとき、コードレスアクセスサブシステムの側の呼出制御メッセージの処理を更に簡単にすることができる。
Patent JP-2001524995-A (JP)
Title: 硬質ポリウレタンフォームの製造方法
IPC: C08J9/12
Filed: 1998-02-13
Abstract: (57)【要約】
（ａ）ポリイソシアネート成分と、（ｂ）ポリオール混合物、（ｃ）触媒および（ｄ）発泡剤からなるポリオール成分とを混合して発泡させる硬質ポリウレタンフォームの製造方法において、ポリイソシアネート成分（ａ）がポリメチレンポリフェニルポリイソシアネートあるいは、その変性体であり、ポリオール混合物（ｂ）が、（ｂ−１）脂肪族アミンにアルキレンオキシドを付加したポリオール、および（ｂ−２）芳香族アミン、芳香環を持つたマンニッヒ塩基、または多官能フェノールを出発物質として製造された芳香族ポリエーテルポリオールからなり、触媒（ｃ）が、少なくとも１種の金属系触媒であり、発泡剤（ｄ）が、１級または２級アミン化合物と二酸化炭素の付加物である製造方法。本発明の方法は、初期活性に優れ、しかも、原液使用量が少ない。
Patent JP-2000517292-A (JP)
IPC: A61P35/00
Filed: 1997-09-12
Abstract: The invention provides compounds of general formula (I), wherein: X is halogen or OSO2R, where R represents H or is unsubstituted or hydroxy- or amino-substituted lower alkyl; Y is a nitro or amine group or a substituted derivative thereof; W is selected from the structures of formulae (Ia, Ib or Ic), where E is -N= or -CH=, G is O, S, or NH, and Q is either up to three of R, OR, NRR, NO2, CONHR, NHCOR or NHCONHR, or is an additional group of formulae (Ia, Ib or Ic) and HET represents a 5- or 6-membered carbocycle or heterocycle; and A and B collectively represent a fused benzene or 2-CO2R pyrrole ring. In one embodiment, the group Y is an amine derivative substituted by a group which is a substrate for a nitroreductase or carboxypeptidase enzyme such that one of said enzymes is able to bring about removal of that group.
Patent JP-2001505317-A (JP)
Title: カブリが減少した超硬調を有するネガを作製するためのハロゲン化銀記録材料
IPC: G03C1/06
Filed: 1997-05-07
Abstract: (57)【要約】
ヒドラジン化合物ならびにコントラスト−増強アミノ化合物及び／又はホスホニウム化合物を含有する超硬調コントラストを有するネガ画像の作製のための写真ハロゲン化銀材料は、不十分なアキュータンスを生ずる「黒カブリ」を生成する顕著な傾向を示す。銀１モル当たり２００〜２５００ｍｇのポリビニルラクタムを乳剤に加えることにより、カブリが妨げられ、感度の低下なしでアキュータンスが向上する。プレプリント段階における再現の間に画像を形成するために本発明を用いることができる。
Patent JP-2000511531-A (JP)
IPC: A61K9/08
Filed: 1997-05-16
Abstract: The invention discloses a process and resuscitation solution for inducing repair of ischemically damaged organs and tissues, to the degree that impairment of function can be reversed; and preventing further tissue damage during restoration of the circulation of the treated organ or tissue. The process comprises flushing the organ with the resuscitation solution according to the present invention at a warm temperature of about 28 DEG  C. to about 37 DEG  C. to remove accumulated blood and acidotic products from blood flow deprivation; and perfusing the flushed organ or tissue with the resuscitation solution, wherein the solution contains a novel combination of components to provide for (i) dilating of the blood vessels within the organ or tissue, (ii) reestablishing organ or tissue function by supplying trophic factors, (iii) restoring cellular integrity and function to the ischemically damaged organ or tissue, and (iv) reestablishing oxidative metabolism by readapting the ischemically damaged organ or tissue, surviving by anaerobic respiration, to an oxygenated resuscitation solution.
Patent JP-2002503429-A (JP)
IPC: H04W52/58
Filed: 1999-02-19
Abstract: A system and method is taught for controlling the power level of transmissions within a communication system having a base station, a mobile station, a communication channel, and a pilot channel. The mobile station determines a signal strength value according to a communication signal received by way of the communication channel. A pilot channel signal is determined according to a pilot signal transmitted by way of the pilot channel. The signal to noise ratio of the communication signal is determined according to the determined signal strength value and the pilot channel signal. The power level of a transmission is controlled according to the signal to noise ratio. The noise level in a communication channel within the communication system is estimated. The pilot channel signal includes pilot energy and pilot noise components. The pilot energy component is removed to provide a remaining pilot signal. Communication system operations are controlled according to the remaining pilot signal. The power levels of transmissions are controlled by determining the signal to noise ratio of a signal within the communication channel and determining a difference signal. The difference signal is formed by determining the difference between determined and desired signal to noise ratios. The difference signal is transmitted between the base station and the mobile station. The pilot channel has at least one frame and the power control signal is inserted into the frame. Thus, information representing the strength of the communication signal is transmitted to the base by way of the pilot channel within the frame. The pilot channel can have two information frames for transmitting the power control signal a plurality of times.
Patent JP-2001527732-A (JP)
Title: デジタル情報信号の算術エンコーディング／デコーディング
IPC: H03M7/00
Filed: 1999-02-22
Abstract: (57)【要約】
音声信号は、周知のシグマ−デルタ変調技術を使用してアナログからデジタルに変換されることが可能である。当該デジタル信号は、その後、例えば２８２２４００Ｈｚ（＝６４＊４４１００Ｈｚ）という周波数における１ビット・サンプルのシーケンスによって構成される。ロスレスコーディング技術は、これらの１ビットの過剰サンプリングされた音声信号に関して、必要な記憶又は伝送の容量を削減するものとして周知である。本発明によれば、１ビットの過剰サンプリングされた音声信号に関する当該ロスレスコーダの性能（圧縮比）が改善され得ることになる。これは当該ロスレスコーダに関する確率信号を時に応じて変更することによって実現される。
Patent MX-160468-A (MX)
Inventor: SWINDERMARN ROBERT TOOD
IPC: B65G45/00
Filed: 1984-07-16
Abstract: A conveyor belt cleaning arrangement consisting of a transversely disposed support which includes a plurality of connector slots. One or more elastomeric cleaner blades, either of the doctor blade type or the arm and blade type, include a locking device to releasably connect the blade to the support without the use of fasteners and secure the blade against lateral motion and hold the blade in position for cleaning the belt.
Patent NZ-191710-A (NZ)
Title: 3-(heteroaryl)-2-(methylsulphinyl)acetyl)indoles
Inventor: STEINMAN M
IPC: A61K31/40
Filed: 1979-10-01
Abstract: This invention relates to compositions of matter classified in the art of chemistry as substituted 2-[(methylsulfinyl)acetyl]-3-heterocyclicindoles, various derivatives thereof, and to the processes for making and using such compositions as immunosuppressants.
Patent NZ-202857-A (NZ)
Title: Preparation of beta-((2-methylpropoxy)methyl)-n-phenyl-n-(phenylmethyl)-1-pyrrolidineethanamine hydrochloride hydrate
Inventor: STIEFEL F J
IPC: C07D/
Filed: 1982-12-20
Abstract: A novel, efficient, economical procedure for the synthesis of ethers of n-propanoldiamine having the formula:   <IMAGE>   wherein R is a straight or branched chain lower alkyl group or an aralkyl group, Ar is an aromatic group, Ar1 is an aromatic or heterocyclic group, A is a tertiary aliphatic, cycloaliphatic or heterocyclic amino group and addition salts thereof with pharmacologically acceptable acids.
Patent NZ-205110-A (NZ)
Title: Halogenation of solid polymeric or metallic material
Inventor: TARANCON G
IPC: B05D7/22
Filed: 1983-08-02
Abstract: The invention deals with a process for the surface halogenation of polymeric or metallic materials. 
<??>This process comprises:
 introducing the material into a chamber;
 heating the chamber and the material to a selected temperature in the range of 38 DEG C to 93 DEG C by recirculating the air through a heat exchanger; evacuating the system; introducing a halogen into the system in an amount (i) of up to about 10 percent in excess of the theoretical amount of halogen required to halogenate the material to a desired depth and (ii) sufficient to provide a partial absolute pressure in the system in the range of 0.007 x 10<5> Pa to 0.21 x 10<5> Pa absolute;
 introducing an inert gas into the system in an amount sufficient to provide a total pressure in the system of about one atmosphere;
 maintaining the selected temperature by recirculating the halogen/inert gas mixture through the heat exchanger;
 recirculating the halogen/inert gas mixture a sufficient number of times to reduce the amount of halogen to less than about 5 percent of the amount of halogen initially introduced into the system;
 evacuating the system;
 introducing air into the system to provide about atmospheric pressure; and
 removing the material.
Patent NZ-210701-A (NZ)
Title: Screw pipe joint with chevron profiled thread form
Inventor: BLOSE T L
IPC: E21B17/042
Filed: 1984-12-21
Abstract: A thread form is shown for a tubular connection of the type having a pin member (13) adapted to be made up with a box member (15) to form a pipe joint. The pin member (13) has pin threads with thread crests (17) and thread roots (19) which are adapted to be made up with a mating box member (15) having a complimentary thread structure. The pin thread crests (17) are formed between a stab flank (25) and a load flank (27) of the pin thread. The pin thread has a chevron-shaped load flank (27) for engaging a mating chevron-shaped load flank of the complimentary box member (15) to provide a chevron type interfit between the load bearing flanks. The load flanks (43) of the pin member includes an outer wall portion (43) with a positive slope which provides additional clearance between the complimentary threads on the pin (13) and box members (15) during disassembly to prevent inadvertent hanging-up of the threads.
Patent NZ-232458-A (NZ)
Title: Fault tolerant memory error correction: each memory unit has lock-up feature
Inventor: BLAKE ROBERT MARTIN
IPC: G06F11/10
Filed: 1990-02-09
Abstract: In a memory system comprising a plurality of memory units (10) each of which possesses unit-level error correction capabilities (20) and each of which are tied to a system level error correction function (30), memory reliability is enhanced by providing means for fixing the output of one of the memory units at a fixed value in response to the occurrence of an uncorrectable error in one of the memory units. This counter-intuitive approach to the generation of forced hard errors nonetheless enhances overall memory system reliability since it enables the employment of the complement/recomplement algorithm which depends upon the presence of reproducible errors for proper operation. Thus, chip level error correction systems, which are increasingly desirable at high packaging densities, are employed in a way which does not interfere with system level error correction methods.
Patent NZ-235827-A (NZ)
Title: Method and apparatus for placing an insert into a container
Inventor: KERSHAW PETER FRANK
IPC: B65B61/20
Filed: 1990-10-25
Abstract: PCT No. PCT/GB90/01599 Sec. 371 Date Mar. 10, 1993 Sec. 102(e) Date Mar. 10, 1993 PCT Filed Oct. 16, 1990 PCT Pub. No. WO91/06481 PCT Pub. Date May 16, 1991.A method of placing an insert in a container having a neck wherein the insert is of greater longitudinal extent than the cross-section of the neck, comprising the steps of holding the insert in a first orientation while causing relative movement between the insert and the container to introduce the insert into the container through the neck and subsequently permitting the insert to move under the influence of gravity into a second, different, orientation relative to the first orientation within the container.
Patent NZ-240801-A (NZ)
Title: Wound dressing product having a roll configuration
Inventor: CARTMELL JAMES VERNON
IPC: A61L15/26
Filed: 1991-11-29
Abstract: The present invention is directed to a wound dressing product (10) having a roll configuration. The wound dressing product (10) comprises a wound dressing laminate (12) having a plurality of layers including a backing layer (18) which forms a first side (14) of the wound dressing laminate (12) and a hydrogel layer (20) which forms a second side (16) of the wound dressing laminate (12). The wound dressing laminate (12) is spirally wrapped about a center axis (22) such that the wound dressing laminate (12) terminates at a leading end (24) and the first side (14) of the wound dressing laminate (12) forms the outer surface of the wound dressing product (10). <IMAGE>
Patent NZ-245724-A (NZ)
Title: Imparting collapse resistance to gas-filled microvesicles incorporated into ultrasonic contrast agents
Inventor: SCHNEIDER MICHEL
IPC: A61K49/22
Filed: 1993-01-21
Abstract: One can impart outstanding resistance against collapse under pressure to gas-filled microvesicle used as contrast agents in ultrasonic echography by using as fillers gases whose solubility in water, expressed in liter of gas by liter of water under standard conditions, divided by the square root of the molecular weight does not exceed 0.003. <IMAGE>
Patent NZ-263080-A (NZ)
Title: N-phenyl-n'-indolylsulphonylurea derivatives
Inventor: GRINDEY GERALD BURR
IPC: A61K31/40
Filed: 1994-03-10
Abstract: This invention provides certain indolinesulfonamide and substituted-indolesulfonamide derivatives of the formula <CHEM>  wherein: <CHEM>  R<1> is C1-C6 alkyl; R<2> and R<3> are independently selected from the group consisting of hydrogen, halo, C1-C6 alkyl, and trifluoromethyl, provided that no more than one of R<2> and R<3> can be hydrogen; and methods for using them in the treatment of susceptible neoplasms in mammals. Also provided are certain novel pharmaceutical formulations employing these indolinesulfonamide and substituted-indolesulfonamide derivatives in combination with a carrier, excipient or diluent, as well as processes for preparing the compounds.
Patent NZ-266354-A (NZ)
Title: Stable compositions of gamma interferon not subjected to prior lyophilization
Inventor: NGUYEN TUE
IPC: A61K47/10
Filed: 1994-05-04
Abstract: The present invention concerns stable liquid pharmaceutical compositions comprising gamma interferon (IFN- gamma , also known as immune interferon). The invention specifically covers stabilized aqueous pharmaceutical compositions comprising multiple doses of a therapeutically effective amount of IFN- gamma  for repeated administration.
Patent NZ-274378-A (NZ)
Title: Dose of powdered medicament embedded in carrier comprising overlapping and intersecting depressions
Inventor: MULHAUSER PAUL
IPC: A61M15/00
Filed: 1994-09-21
Abstract: A carrier impregnated at spaced locations along its circumference with a dose of powdered medicament. The carrier is selectively indexed so as to present the impregnated doses of medicament seriatim between a pair of holes in an upper and lower pressure plate in an inhalator. Air is forced through the holes in the pressure plates and the encapsulated dose on the carrier to entrain a dose of the powdered medicament, which is then inhaled through a mouthpiece, by the patient-user. The powdered medicament is embedded in and across interstices in the carrier formed by intersecting and sometimes offset depressions on each surface of the carrier, providing corners and surfaces to cause the medicament entrained in the air stream to break up as it is pressed up against and passed through the carrier infrastructure to aerosol or atomize the same so that the medicament is presented in appropriate particle sizes for maximum benefit when inhaled.
Patent NZ-279516-A (NZ)
Title: Wound dressing, which is non-adherent and absorbent, comprising textile fibres and gel forming fibres
Inventor: LYDON MICHAEL JAMES
IPC: A61L15/22
Filed: 1995-01-20
Abstract: The invention provides a wound dressing comprising in sheet form a mixture of textile fibers and gel forming fibers. The wound dressing according to the invention may have the advantages that it is non-adherent to wound tissue while being absorbent and relatively inexpensive.
Patent NZ-282790-A (NZ)
Title: Using a recombinant inhibitor from erythrina caffra to purify serine proteases
Inventor: KOHNERT ULRICH
IPC: C12P21/02
Filed: 1995-03-13
Abstract: PCT No. PCT/EP95/00926 Sec. 371 Date Sep. 13, 1996 Sec. 102(e) Date Sep. 13, 1996 PCT Filed Mar. 13, 1995 PCT Pub. No. WO95/25168 PCT Pub. Date Sep. 21, 1995Process for purifying serine proteases from a protein mixture by binding the serine protease to an immobilized polypeptide with the activity of an inhibitor DE-3 from Erythrina caffra, removing unbound components from the protein mixture, detaching the serine protease from the inhibitor and separating the immobilized inhibitor from the soluble serine protease and isolating serine protease which is characterized in that a polypeptide is used as the polypeptide which is the product of a prokaryotic or eukaryotic expression of an exogenous nucleic acid. This inhibitor is distinguished by an improved specific activity and is particularly suitable for the purification of plasminogen activators such as tissue plasminogen activators (t-PA and derivatives).
Patent NZ-286765-A (NZ)
Title: Backpack, m-shaped vertical stay of frame has an upper and lower convex part and a middle concave part
Inventor: TATE AARN
IPC: A45F3/08
Filed: 1996-06-07
Abstract: A backpack (10) has a compartment (12) for items to be transported on the back of a carrier and a back frame (18) comprising at least one vertical stay (20) having a top end and a bottom end and at least one horizontal stay (22, 24), the vertical stay being generally S-shaped and the horizontal stay having a generally concave shape, at least one of the stays being made of a material that can be deformed to a desired shape. <IMAGE>
Patent NZ-299785-A (NZ)
Title: Echo canceller digital filter transfer function updating
Inventor: MAURER MICHAEL
IPC: H04M9/08
Filed: 1996-11-20
Abstract: The echo compensator (5) is inserted between a transmission line (1) and a reception line (2) of a communication system and uses digital filters for determining the transfer function. The transfer function is then adjusted to simulate a real system by updating the filter coefficients when the result of a correlation between a defined number of sample values of the transmitted signal and the corresponding echo signal values exceeds a threshold value.
Patent NZ-300419-A (NZ)
Title: Diaphragm pump airless sprayer with inlet valve
Inventor: CONATSER ROGER
IPC: B05B12/00
Filed: 1995-12-13
Abstract: An airless paint sprayer (10) includes a dampener to lessen cavitation and loss of pressure in the paint sprayer (10). The dampener comprises a generally T-shaped fitting (36) in which one leg (46) is capped and includes a trapped volume of air (52) to dampen acceleration/deceleration forces and acceleration spikes being transmitted from the pump (20) to the fluid being pumped through the fitting (36).
Patent NZ-330292-A (NZ)
Title: Imidazoquinazoline derivatives
Inventor: NONE PROVIDED
IPC: C07D487/04
Filed: 1997-08-29
Abstract: midazoquinazoline derivatives represented by general formula (I) or pharmacologically acceptable salts thereof.  These compounds have potent and selective inhibitory effects on cyclic guanosine-3',5'-monophosphate (cGMP)-specific phosphodiesterase and are useful in, for example, treating or relieving cardiovascular diseases such as thrombosis, angina pectoris, hypertension, cardiac insufficiency and arteriosclerosis, asthma, etc. and treating sexual impotence.  R1 represents hydrogen, optionally substituted lower alkyl, optionally substituted cycloalkyl, optionally substituted bicycloalkyl, optionally substituted tricycloalkyl, etc.  R2 represents hydrogen, optionally substituted lower alkyl, optionally substituted cycloalkyl, optionally substituted bicyclaolkyl, optionally substituted tricycloalkyl, optionally substituted lower alkenyl, optionally substituted aralkyl, etc.  R3 represents hydrogen, optionally substituted lower alkyl, optionally substituted cycloalkyl, optionally substituted bicycloalkyl, optionally substituted tricycloalkyl, optionally substituted lower alkenyl, optionally substituted aralkyl, etc.   R2 and R3 may form together with N an optionally substituted heterocyclic group.  X represents O or S.  Divisional filed as 334757
Patent NZ-332062-A (NZ)
Title: Carton box made out of several blanks and having triangular corner columns
Inventor: TSAMOURGELIS ILIAS
IPC: B65D5/32
Filed: 1997-06-30
Abstract: A carton, for packing and transportation of agricultural and industrial products, consists of sides A1, A3, A4, A5, base A2 and folded and glued together extensions F1-F8.  At small sides A4, A5 triangular columns K1-K4 and projections P1-P4 are formed.  At all sides cuttings are made so that slots E1-E4 accommodate projections P1-P4 when like cartons are stacked.
Patent NZ-332823-A (NZ)
Title: ,5-Diimino-3a,6a-diaryl-1,2,3,3a,4,5,6,6a-octahydroimi dazo[4,5-d]imidazoles as non-peptide G-CSF mimetics
Inventor: LUENGO JUAN I
IPC: C07D487/04
Filed: 1997-05-22
Abstract: Compounds of the above formula that act as G-CSF mimetics are useful for enhancing leukocyte production and treating neutropenia. Formula (I) comprises the following substituents: R1, R2, R3 and R4 are aryl, R6 is hydrogen or alkyl n is 0-2 R7 is hydrogen or alkyl R5 is hydrogen, cycloalkyl, C6-C12aryl, substituted cycloalkyl, substituted C6-C12aryl, alkyl or substituted alkyl. Also described is a process for the preparation of the above formula and pharmaceutical compositions comprising said G-CSF mimetics.